Prognostic Value of Prostata Specific Antigen and Digital Rectal Examination at Prostate Biopsy

1 MB Culp, I Soerjomataram, JA Efstathiou, et al.: Recent global patterns in prostate cancer incidence and mortality rates. Eur Urol. 2019 Epub ahead of print Search in Google Scholar

2 Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9-29. Search in Google Scholar

3 H Lilja: Prostate-specific antigen: molecular forms and the human kallikrein gene family. Br J Urol. 79. 2017; (Suppl 1):44-48 1997. Search in Google Scholar

4 Sayyid RK, Alibhai SMH, Sutradhar R, Eberg M, Fung K, Klaassen Z, et all. Population-based outcomes of men with a single negative prostate biopsy: Importance of continued follow-up among older patients. Urol Oncol. 2019;37(5):298.e19-298.e27. Search in Google Scholar

5 Trabul s i EJ, Halpern EJ, Gomella LG. Ultrasonography and biopsy of the prostate. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, th Peters CA, editors. Campbell-Walsh urology. 10 ed. Philadelphia: Elsevier Saunders; 2012. pp2735-2747. Search in Google Scholar

6 Matlaga BR, Eskew LA, McCullough DL. Prostate biopsy: indications and technique. J Urol. 2003; 169(1):12-9. Search in Google Scholar

7 Vida AO, Szollosi A, Maier A, Boja RM, Orsolya M. The Management of the patient with elevated prostate specific antigen and a negative initial prostatebiopsy. ActaMedica Marisiensis. 2015;61(1):7-9. Search in Google Scholar

8 Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC et al. Comparison of digital rectal examination and serum prostate specifc antigen in the early detection of prostate cancer. Result of multicentre clinical trial of 6,630 men. J Urol. 1994; 15:1283-1290. Search in Google Scholar

9 Torp-Peder son S, Juul N, Jakobsen H. Transrectal prostatic ultrasonography. Equipment, normal ndings, benign hyperplasia and cancer. Scand J Urol Nephrol. Suppl 1998;107:19-25. Search in Google Scholar

10 McNaughton CM, Ransohoff DF, Barry MJ. Early detection of prostate cancer. Serendipity strikes again. 1997; 278(18):1516-1519. Search in Google Scholar

11 Kash DP, Lal M, Hashmi AH, Mubarak M. Utility of digital rectal examination, serum prostate specific antigen, and transrectal ultrasound in the detection of prostate cancer: A developing country perspective. Asian Pac J Cancer Prev 2014; 15(17):3087-3091. Search in Google Scholar

12 Abdrabo AA, Fadlalla AI, Fadl-Elmula IM. Significance of serum total prostate-specific antigen and digital rectal examination in the diagnosis of prostate cancer. Saudi Med J. 2011; 32:1133-1136. Search in Google Scholar

13 Beemsterboer PM, de Koning HJ, Kranse R, Trienekens PH, van der Maas PJ, Schröder FH. Prostate specific antigen testing and digital rectal examination before and during a randomized trial of screening for prostate cancer: European randomized study of screening for prostate cancer, Rotterdam. J Urol. 2000;164(4):1216-20. Search in Google Scholar

14 Schröder FH, Hugosson J, Carlsson S, Tammela T, Määttänen L, Auvinen A, Kwiatkowski M, et al. Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC). Eur Urol. 2012; 62(5):745-52. Search in Google Scholar

15 Roobol MJ, Zappa M, Määttänen L, Ciatto S. The value of different screening tests in predicting prostate biopsy outcome in screening for prostate cancer data from a multicenter study (ERSPC). Prostate. 2007;67(4):439-46. Search in Google Scholar

16 Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. Association of Urology. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intentupdate 2013. Eur Urol. 2014; 65(1):124-37. Search in Google Scholar

17 Barry M (2006). The PSA conundrum. Arch Intern Med, 166, 7-8. Search in Google Scholar

18 Alibhai SMH, Naglie G, Nam R, et al. Do older men benefit from curative therapy of localized prostate cancer? J Clin Oncol 2003; 21, 3318-27. Search in Google Scholar

19 Nomikos M, Mariappan P, Zachou A, McNeill A, Bollina PR. Could prostate biopsies be avoided in men older than 75 years with raised PSA? Urol Int. 2010; 85(4):410-4. Search in Google Scholar

20 Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Beh Res Methods 2007; 39(2):175 191. Search in Google Scholar

21 Bhusan Raj Timilsina, Gaurav Devkota, Shweta Giri, Sulav Pradhan, Sudeep Raj KC. Relationship of prostate specific antigen and digital rectal examination in the prediction of prostate cancer. JCMS. 2020. (16):2. Search in Google Scholar

22 Dudith Pierre-Victor, Howard L. Parnes, Gerald L. Andriole, and Paul F. Pinsky. Prostate cancer incidence and mortality following a megative biopsy in a population undergoing PSA screening. Urology. 2021. 155:62-69. Search in Google Scholar

23 Institut za javno zdravlje ''dr Milan Jovanovic-Batut''. Maligni tumori u Republici Srbiji. Dostupno na: https://www.batut.org.rs/. Poslednji put vidjeno: 16.12.2022. godine. Search in Google Scholar

24 Nikola P, Darko L. Diagnostic value of serum prostatespecific antigen in patients with potentially curable prostatic carcinoma. Medica Medianae. 2017. 56(1):5-8. Search in Google Scholar

25 Louise K. Makau-Barasa, Achille Manirakiza, Andre L. Carvalho4, Timothy R. Rebbeck. Prostate cancer screening, diagnostic, treatment procedures and costs in Sub-Saharan Africa: A situational analysis. Prostate Cancer in Underserved Populations. 2022. (29): 1-15. Search in Google Scholar

26 Mbaeri TU, Nwadi U, Abiahu JA, Orakwe JC, Okoli C. Correlation between prostate specific antigen, digital rectal examination and histology in patients with prostate cancer. Niger J med. 2018. 212-218. Search in Google Scholar

27 Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: Int J Cancer. 2010. 15;127(12):2893-917. Search in Google Scholar

28 Sakaguchi K, Hayashida M, Tanaka N, Oka S, Urakami S. A risk model for detecting clinically significant prostate cancer based on bi-parametric magnetic resonance imaging in a Japanese cohort. Sci Rep. 2021. 22;11(1):18829. Search in Google Scholar

29 Gordana Djordjevic, Sanja Stifter, Christophe Stemberger. Pathohistological diagnosis of prostate cancer. Medicina fluminensis. 2017. (53):3, p. 252-263. Search in Google Scholar

30 Ojewola RW, Tijani KH, Jeje EA, Ogunjimi MA, Anunobi CC, Adesanya AO. An evaluation of usefulness of prostate specific antigen and digital rectal examination in the diagnosis of prostate cancer in an unscreened population:experience in a Nigerian teaching hospital. West Afr J Med. 2013. 32(1):8-13. Search in Google Scholar

31 Nomikos M, Mariappan P, Zachou A, McNeill A, Bollina PR. Could prostate biopsies be avoided in men older than 75 years with raised PSA? Urol Int. 2010; 85(4):410-4. Search in Google Scholar

32 Lazarovich A, Raviv G, Laitman Y, Portnoy O, Raz O, Dotan ZA, Ramon J, Rosenzweig B. Histology results of systematic prostate biopsies by in-bore magnetic resonance imaging vs. transrectal ultrasound. Can Urol Assoc J. 2021. 5(5):E244-E247. Search in Google Scholar

33 Makau-Barasa LK, Manirakiza A, Carvalho AL, Rebbeck TR. Prostate Cancer Screening, Diagnostic, Treatment Procedures and Costs in Sub-Saharan Africa: A Situational Analysis. Cancer Control. 2022. 29:107-21. Search in Google Scholar